Log In
Print
BCIQ
Print
Print this Print this
 

MK-2206

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionProtein kinase B (PKB; PKBA; AKT; AKT1) inhibitor
Molecular Target Protein kinase B (PKB) (PKBA) (AKT) (AKT1)
Mechanism of ActionAkt inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today